The rise of neo: Neoadjuvant anti-PD1 in melanoma | 20 mins
743
students
1
Free
The availability of neoadjuvant immunotherapy is changing the way Stage III melanoma is managed. In this recorded presentation for our Melanoma Nurse In-Service Series,...
Free
Neoadjuvant immunotherapy: Revolutionising melanoma treatment | 36 min
2420
students
2
Free
Our latest podcast explores the innovative approach of neoadjuvant immunotherapy – administering checkpoint inhibitor immunotherapy before the surgical removal of melanoma. This promising approach...
Free
The critical role of standardised pathological assessment in neoadjuvant therapy for melanoma: A guide for Pathologists | 40 min
2600
students
0
Free
The role of the Pathologist is crucial in the emerging field of neoadjuvant therapy in melanoma. Understanding that their role is fundamental to patient...
Free
Refining pathological response assessment in neoadjuvant therapy for melanoma | 40 min
2637
students
1
Free
In this presentation, Pathologist Prof Richard Scolyer AO discusses how neoadjuvant therapy is transforming melanoma patient care. He also answers key questions around neoadjuvant-treated...
Free
Neoadjuvant therapy in melanoma: The perfect model | 12 min
3288
students
0
Free
‘To shave or not to shave, that is the question.’ In this engaging debate, Dermatologist A/Prof Victoria Mar and Surgeon Prof Michael Henderson present...
Free
Neoadjuvant therapy in melanoma: Implications for primary care | 25 min
3478
students
0
Free
This presentation was recorded at the 2021 Australasian Skin Cancer Congress, organised by the Skin Cancer College Australasia. In this presentation, Medical Oncologist A/Prof...
Free
Neoadjuvant therapy in melanoma with Georgina Long | 45 min
3719
students
0
Free
In this interview from Oncology News Australia, MIA’s Prof Georgina Long AO speaks with Prof Hans Prenen on a recent publication in Nature Medicine...
Free